+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


C-reactive Protein Testing - Global Market Trajectory & Analytics

  • ID: 5028027
  • Report
  • April 2021
  • Region: Global
  • 199 Pages
  • Global Industry Analysts, Inc
Global C-reactive Protein Testing Market to Reach $1.8 Billion by 2027

Amid the COVID-19 crisis, the global market for C-reactive Protein Testing estimated at US$1.6 Billion in the year 2020, is projected to reach a revised size of US$1.8 Billion by 2027, growing at a CAGR of 1.4% over the analysis period 2020-2027. Cardiovascular Diseases, one of the segments analyzed in the report, is projected to record a 1.8% CAGR and reach US$531.7 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Cancer segment is readjusted to a revised 1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $466 Million, While China is Forecast to Grow at 1.1% CAGR

The C-reactive Protein Testing market in the U.S. is estimated at US$466 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$308.6 Million by the year 2027 trailing a CAGR of 1.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.4% and 0.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.3% CAGR.

Rheumatoid Arthritis Segment to Record 1.7% CAGR

In the global Rheumatoid Arthritis segment, USA, Canada, Japan, China and Europe will drive the 1.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$170.1 Million in the year 2020 will reach a projected size of US$191.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$196.1 Million by the year 2027.

Select Competitors (Total 43 Featured):
  • Abaxis, Inc.
  • Abbott Laboratories
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Laboratory Corporation of America Holdings (LabCorp)
  • Merck KgaA
  • Quest Diagnostics, Inc.
  • Randox Laboratories Ltd.
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
Frequently Asked Questions about the Global Market for C-reactive Protein Testing

What is the estimated value of the Global Market for C-reactive Protein Testing?

The Global Market for C-reactive Protein Testing was estimated to be valued at $1.6 Billion in 2020.

What is the growth rate of the Global Market for C-reactive Protein Testing?

The growth rate of the Global Market for C-reactive Protein Testing is 1.7%, with an estimated value of $1.8 Billion by 2027.

What is the forecasted size of the Global Market for C-reactive Protein Testing?

The Global Market for C-reactive Protein Testing is estimated to be worth $1.8 Billion by 2027.
Note: Product cover images may vary from those shown

  • Influencer Market Insights
  • Impact of COVID-19 Pandemic and Looming Global Recession
  • What is C-reactive Protein (CRP)?
  • An Introduction to C-reactive Protein Testing
  • Global Market Prospects & Outlook
  • Immunoturbidimetric Assays: The Major Segment by Assay Type
  • hs-CRP Test Type Leads by Detection Range
  • Cardiovascular Diseases Emerge As the Leading Disease Type for CRP Testing, Cancer Detection to Make Strong Gains
  • Clinics & Hospitals Hold Dominant Share of CRP Testing Market
  • Developed Regions Lead, Developing Economies to Spur Market Growth
  • Rising Prominence of POC Testing Approaches for C-reactive Protein Testing Enable Faster and Accurate Results
  • Growing Approval for CRP Testing for Identification of Bacterial and Non-Bacterial Diseases to Propel Market Growth
  • CRP Testing for Ascertaining Viral Infections
  • Growing Incidence of HIV Infections and Need for Monitoring of HIV Diseases Drive CRP Testing
  • Rising Importance of CRP Testing for Cardiovascular Diseases
  • Exhibit 1: Cardiovascular Disease Incidence Rates (per 100,000) by Select Countries
  • Rising Prevalence of Inflammatory Diseases: Opportunity for CRP Testing
  • Threat of Endometriosis in Women: Significant Role of CRP Testing
  • CRP Testing: A Vital Diagnostic Tool for Cancer
  • Advancements in CRP Testing Methods
  • CRP Testing Holds Potential Role in Assessing Effectiveness of Antibiotic Drugs
  • Funding Support for Extensive Research on Applications of C-reactive Protein Testing to Boost Market Growth
  • CRP Testing Brings to Light Issues Related to Data Integrity & Testing Reliability


  • Total Companies Profiled: 43
Note: Product cover images may vary from those shown